[taylor&francis] Tislelizumab for consolidation therapy in patients with pathologically residual Esophageal Squamous Cell Carcinoma after definitive concurrent Chemoradiotherapy: a multicenter, randomized, controlled phase II trial |
发布
回复
积分
0
10
Current status of porous coordination networks (PCNs) derived porphyrin spacers for cancer therapy
10
Vocational education, earnings and job satisfaction in Europe
10
Macrophage-derived exosomes carrying RAD50 attenuate oxidative DNA damage and p53–p21-dependent S-phase arrest in spermatogenic cells
10
Exploring AI chatbot affordances in the EFL classroom: young learners’ experiences and perspectives